Jefferies initiated coverage on VBI Vaccines with a new price target
$VBIV
Biotechnology: Pharmaceutical Preparations
Health Care
Jefferies initiated coverage of VBI Vaccines with a rating of Buy and set a new price target of $7.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
11/11/2022 | $5.00 → $2.00 | Strong Buy → Outperform | Raymond James |
3/8/2022 | $9.00 → $6.00 | Strong Buy | Raymond James |
12/29/2021 | $7.00 → $6.00 | Buy | Jefferies |